BeStock  
Stocks › Biotechnology › OCUL

Ocular Therapeutix OCUL

US equityMarket cap rank #2935Biotechnology
$7.25 +$0.29 (+4.17%)
Pre-market · Oct 6, 4:10 am ET · After hours $7.25 -0.02%
Open$6.93
Prev close$6.96
Day range$6.79 – $7.27
Volume5.62M
Market cap$1.59B
P/E (TTM)–
Dividend yield–

Ownership & positioning

Who holds it, who is betting against it, and where the big money is moving

Institutional ownership95.1%+0.40 pts vs. prior quarter
Institutions holding307+0 vs. prior quarter
Insider trades (recent)22 buys / 28 sellsNet selling
Short interest13.63% of floatDays to cover 14.2 · as of 15 Sep 2026
Short-sale volume share16.5%5-day average of daily volume

Short-sale volume as % of daily volume

12%16%20%25%Sep '26Sep '26Oct '26

Large-order net flow, last 20 sessions

Net of large-order buying minus selling, in USD. Over this window: −$844.1K (10 inflow days, 10 outflow days).

The five largest holders on file together own 44.0% of shares outstanding.

Largest holders

  • FMR14.96%
  • Deep Track Capital, LP8.96%
  • BlackRock8.82%
  • Avoro Capital Advisors LLC5.71%
  • Summer Road LLC5.56%
  • VR Management, LLC4.71%
  • Vanguard Capital Management, LLC4.61%
  • T. Rowe Price Group, Inc.3.47%

By investor type

  • Mutual Fund51.18%
  • Hedge Fund19.38%
  • VC/PE Fund15.05%
  • Family Office/Trust5.63%
  • Public Company2.09%
  • Individual/Insider1.20%
  • Private Company1.05%
  • Insurance Company0.41%

Reported short interest has risen from 12.19% to 13.63% of float over the last 6 biweekly reports (30 Jun 2026 to 15 Sep 2026).

Short interest, by report

Report dateShares short% of floatDays to cover
15 Sep 2026 29,933,140 13.6% 14.2
31 Aug 2026 28,055,522 12.8% 9.0
14 Aug 2026 28,515,335 13.0% 12.7
31 Jul 2026 26,735,397 12.2% 13.5
15 Jul 2026 27,027,521 12.3% 13.1
30 Jun 2026 26,695,136 12.2% 6.6

Discussion

No comments yet — be the first to weigh in on OCUL.

Leave a comment

Scroll to Top